Advertisement

Citation tools

Erba, Harry P. et al "Phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in relapsed/refractory acute myeloid leukemia." Blood Advances 3.13 (2019): 1939-1949. Web. 19 July. 2019.